参考文献/References:
[1] 王亚芳 , 王梅 , 宋爱凤 . 强直性脊柱炎患者外周血Th17/Treg 平衡状态对疾病状况的评估价值 [J]. 国际检验医学杂志 , 2020, 41(7):842-845. WANG Yafang, WANG Mei, SONG Aifeng. Evaluationvalue of peripheral Th17/Treg balance in patients withankylosing spondylitis[J].International Journal ofLaboratory Medicine, 2020, 41(7):842-845.
[2] VERMA I, KRISHAN P, SYNGLE A. Predictors ofatherosclerosis in ankylosing spondylitis[J]. RheumatolTher, 2015, 2(2):173-182.
[3] 郭连峰 , 牟娜 , 刘兆玮 , 等 . 老年急性脑梗死患者血清CRP，VEGF及YKL-40水平动态变化及相关性[J].中国老年学杂志 , 2020, 40(1):14-19. GUO Lianfeng, MOU Na, LIU Zhaowei, et al.Dynamic changes and correlation of serum CRP,VEGF and YKL-40 levels in elderly patients with acutecerebral infarction[J].Chinese Journal of Gerontology,2020, 40(1):14-19.
[4] 夏芳 , 汪隆海 , 方超 , 等 . 血清 5 种生物标志物水平联合检测对心力衰竭的诊断价值 [J]. 现代检验医学杂志 ,2019,34(4):22-27. XIA Fang, WANG Longhai, Fang Chao, et al.Combined detection of serum 5 biomarkers for thediagnostic value of heart failure[J]. Journal of ModernLaboratory Medicine, 2019,34(4):22-27.
[5] VAN DYKEN S J, LOCKSLEY R M. Chitins andchitinase activity in airway diseases[J]. J Allergy ClinImmunol, 2018, 142(2):364-369.
[6] 中华医学会风湿病学分会 . 强直性脊柱炎诊断及治疗指南 [J]. 中华风湿病学杂志 , 2010, 14(8):557-559. Chinese Rheumatology Association. Guidelines for thediagnosis and treatment of ankylosing spondylitis[J].Chinese Journal of Rheumatology, 2010, 14(8):557-559.
[7] GARRETT S, JENKINSON T, KENNEDY L G, et al.A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis DiseaseActivity Index[J]. J Rheumatol, 1994, 21(12):2286-2291.
[8] LALIN A, GARRETT S, Whitelock H, et al. A newapproach to defining functional ability in ankylosingspondylitis: the development of the Bath AnkylosingSpondylitis Functional Index[J]. J Rheumatol, 1994,21(12):2281-2285.
[9] ?OSI?SKA K, KORKOSZ M, KWA?NY-KROCHINB. Endothelial dysfunction in patients with ankylosingspondylitis[J]. Reumatologia, 2019, 57(2):100-105.
[10] Ozdowska P, Wardziak ?, Kruk M, et al. Increasedprevalence of subclinical coronary atherosclerosis inyoung patients with ankylosing spondylitis[J]. Pol ArchIntern Med, 2018, 128(7/8):455-461.
[11] KJAERGAARD A D, JOHANSEN J S, BOJESENS E, et al. Role of inflammatory marker YKL-40 inthe diagnosis, prognosis and cause of cardiovascularand liver diseases[J]. Crit Rev Clin Lab Sci, 2016,53(6):396-408.
[12] 严雯 , 孙波 , 任建功 . 脑梗死患者颈动脉粥样硬化斑块与血清 YKL-40 关系的 meta 分析 [J]. 临床荟萃 ,2018, 33(8):700-704. YAN Wen, SUN Bo, REN Jiangong. Meta-analysis of therelationship between carotid atherosclerotic plaque andserum YKL-40 level in atherosclerotic cerebral infarctionpatients[J].Clinical Focus, 2018, 33(8):700-704.
[13] ?CIBORSKI K, KULICZKOWSKI W, KAROLKO B,et al. Plasma YKL-40 levels correlate with the severityof coronary atherosclerosis assessed with the SYNTAXscore[J]. Pol Arch Intern Med, 2018, 128(11):644-648.
[14] WU S, HSU L A, CHENG S T, et al. Circulating YKL40 level,but not ChI3LI gene variants,is associatedwith atherosclerosis-related quantitative traits and therisk of peripheral artery disease[J]. Int J Mol Sci, 2014,15(12):22421-22437.
[15] KIJAERGAARD A D, JOHANSEN J S, BOJESEN SE, et al. Role of inflammatory marker YKL-40 in thediagnosis,prognosis,and cause of cardiovascular and liverdisease[J]. Crit Rev Clin Lab Sci, 2016, 53(6):396-408.
[16] 贾晨红 , 哈生林 , 姜金坪 , 等 . 慢性心力衰竭患者血清 Galectin-3，hs-cTnT，Cys C 和 PTX-3 水平变化及临床意义 [J]. 现代生物医学进展 , 2020, 20(14):2672-2675. JIA Chenhong, HA Shenglin, JIANG Jinping, et al.Changes and clinical significance of serum galectin-3, hs-cTnT, Cys C and PTX-3 in patients with chronicheart failure[J]. Progress in Modern Biomedicine, 2020,20(14):2672-2675.
[17] 高婉琴 , 李小丹 , 杨朋康 , 等 . 血 清 Galectin-3 和sST2 水平检测用于保留射血分数心力衰竭的生物标记物的研究 [J]. 现代检验医学杂志 ,2019,34(6):54-59. GAO Wan Qin, LI Xiao Dan, YANG Pengkang,et al.Serum on Galectin-3 and sST2 used asbiomarkers for heart failure patient with presrvedejection fraction[J].Journal of Modern LaboratoryMedicine,2019,34(6):54-59.
[18] AGNELLO L, BIVONA G, LO SASSO B, et al.Galectin-3 in acute coronary syndrome[J]. ClinBiochem, 2017, 50(13/14):797-803.
[19] OYENUGA A, FOLSOM A R, FASHANU O, etal. Plasma Galectin-3 and sonographic measures ofcarotid atherosclerosis in the atherosclerosis risk incommunities study[J]. Angiology, 2019, 70(1):47-55.
[20] ANYFANTI P, GKALIAGKOUSI E, GAVRIILAKIE, et al. Association of galectin-3 with markers ofmyocardial function, atherosclerosis, and vascularfibrosis in patients with rheumatoid arthritis[J]. ClinCardiol, 2019, 42(1):62-68.
[21] OU H C, CHOU W C, HUNG C H, et al. Galectin-3aggravates ox-LDL-induced endothelial dysfunctionthrough LOX-1 mediated signaling pathway[J]. EnvironToxicol, 2019, 34(7):825-835.
[22] KUUSK S, S?RLIE M, V?LJAM?E P. Humanchitotriosidase is an endo-processive enzyme[J]. PLoSOne, 2017, 12(1):e0171042.
[23] JAMES A J, REINIUS L E, VERHOEK M, et al.Increased YKL-40 and chitotriosidase in asthma andchronic obstructive pulmonary disease[J]. Am J RespirCrit Care Med, 2016, 193(2):131-142.
[24] 崔雨佳 , 刘忠 . 外周血嗜酸性粒细胞水平与慢性阻塞性肺疾病急性加重期患者临床预后的相关性分析[J]. 现代检验医学杂志 , 2020, 35(3):129-132, 164. CUI Yujia, LIU Zhong. Relationship betweenperipheral blood eosinophil level and the prognosis ofpatients with acute exacerbation of chronic obstructivepulmonary disease[J]. Journal of Modern LaboratoryMedicine, 2020, 35(3):129-132, 164.
[25] JUNG Y Y, KIM K C, PARK M H, et al. Atherosclerosis is exacerbated by chitinase-3-like-1 in amyloid precursor protein transgenic mice[J]. Theranostics, 2018,8(3):749-766.
[26] DI ROSA M, MALAGUARNERA L. Chitotriosidase: Anew inflammatory marker in diabetic complications[J]. Pathobiology, 2016, 83(4):211-219.
相似文献/References:
[1]孙灵迪a,王平均b,鹿 永a,等.HLA-B27基因表达量及亚型分析在AS疾病评估中的意义[J].现代检验医学杂志,2016,31(01):58.[doi:10.3969/j.issn.1671-7414.2016.01.016]
SUN Ling-dia,WANG Ping-junb,LU Yonga,et al.Significance of the Expression Quantity of HLA-B27 Gene
and Its Subtype in Estimating Patients with Ankylosing Spondylitis[J].Journal of Modern Laboratory Medicine,2016,31(03):58.[doi:10.3969/j.issn.1671-7414.2016.01.016]
[2]王 森,高 硕,徐学静,等.强直性脊柱炎患者外周血单个核细胞中Toll样受体表达及功能的研究[J].现代检验医学杂志,2016,31(02):60.[doi:10.3969/j.issn.1671-7414.2016.02.018]
WANG Sen,GAO Shuo,XU Xue-jing,et al.Expression Profiles and Function of Toll-like Receptors in
Peripheral Blood Mononuclear Cells of Ankylosing Spondylitis Patients[J].Journal of Modern Laboratory Medicine,2016,31(03):60.[doi:10.3969/j.issn.1671-7414.2016.02.018]
[3]王平均a,孙灵迪b,武晓茜b,等.HLA-B27表达量在评估强直性脊柱炎患者疾病状况中的作用[J].现代检验医学杂志,2015,30(05):153.[doi:10.3969/j.issn.1671-7414.2015.05.049]
WANG Ping-juna,SUN Ling-dib,WU Xiao-qianb,et al.Roles of the Expression Intensity of HLA-B27
in Estimating Patients with Ankylosing Spondylitis[J].Journal of Modern Laboratory Medicine,2015,30(03):153.[doi:10.3969/j.issn.1671-7414.2015.05.049]
[4]张 静a,董松武b,孙 峰a.ROC 曲线设置流式细胞术检测 HLA-B27 的临界值在强直性脊柱炎诊断和鉴别诊断中的应用[J].现代检验医学杂志,2020,35(06):153.[doi:doi:10.3969/j.issn.1671-7414.2020.06.037]
ZHANG Jing a,DONG Song-wu b,SUN Feng a.Application of ROC Curve of Setting HLA-B27 Critical Value in theDiagnosis and Differential Diagnosis of Ankylosing Spondylitis[J].Journal of Modern Laboratory Medicine,2020,35(03):153.[doi:doi:10.3969/j.issn.1671-7414.2020.06.037]
[5]曹俊杰a,罗改莹a,王 瑞b.外周血C-反应蛋白与清蛋白比值及红细胞分布宽度检测对强直性脊柱炎的诊断价值[J].现代检验医学杂志,2021,36(06):136.[doi:10.3969/j.issn.1671-7414.2021.06.029]
CAO Jun-jie,LUO Gai-ying,WANG Rui.Clinical Value of Peripheral Blood C-reactive Protein to Albumin Ratio and Red Blood Cell Distribution Width in Diagnosis of Ankylosing Spondylitis[J].Journal of Modern Laboratory Medicine,2021,36(03):136.[doi:10.3969/j.issn.1671-7414.2021.06.029]
[6]严鸣光,方 晓,李汶轩,等.强直性脊柱炎模型小鼠踝关节组织和临床患者PBMC 中miR-142-5p，SOCS1 mRNA 表达及与免疫功能分析研究[J].现代检验医学杂志,2024,39(03):29.[doi:10.3969/j.issn.1671-7414.2024.03.005]
YAN Mingguang,FANG Xiao,LI Wenxuan,et al.Expression of miR-142-5p, SOCS1 mRNA in Ankle Joint Tissue Spondylitis Model Mice and PBMC of Clinical Patients and Their Immune Function Analysis[J].Journal of Modern Laboratory Medicine,2024,39(03):29.[doi:10.3969/j.issn.1671-7414.2024.03.005]